ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ECOTRIN
Arthritis/rheumatic disorders
Thromboembolic disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ECOTRIN OTC

Generic Name and Formulations:
Aspirin 81mg, 325mg, 500mg; e-c tabs.

Company:
Prestige Brands, Inc.

Therapeutic Use:

Indications for ECOTRIN:

Arthritic and rheumatic conditions.

Adult:

Rheumatoid arthritis, arthritis and pleurisy of SLE: initially 3g daily in divided doses; target plasma salicylate level 150–300mcg/mL. Osteoarthritis: up to 3g/day in divided doses. Spondyloarthropathies: up to 4g/day in divided doses.

Children:

JRA: initially 90–130mg/kg per day in divided doses; target plasma salicylate level 150–300mcg/mL.

Contraindications:

NSAID allergy. Viral infection in children and teenagers. 3rd trimester pregnancy.

Warnings/Precautions:

History of asthma or peptic ulcer. Severe hepatic or renal dysfunction. Bleeding disorders. Diabetes. Gout. Pregnancy, nursing mothers: not recommended.

Interactions:

Potentiates anticoagulants, hypoglycemics, methotrexate, acetazolamide, valproic acid, highly protein-bound drugs. Urinary alkalinizers, antacids, corticosteroids may increase excretion. May antagonize ACE inhibitors, β-blockers, diuretics, uricosurics. Increased bleeding risk with NSAIDs or chronic, heavy alcohol use. NSAIDs increase risk of renal dysfunction.

Pharmacological Class:

Salicylate.

Adverse Reactions:

GI upset/bleed, prolonged bleeding time, anaphylaxis, salicylism.

How Supplied:

Tabs 81mg—36, 120; 325mg—100, 250; 500mg—60, 150

Indications for ECOTRIN:

To reduce combined risk of death and nonfatal stroke after ischemic stroke or TIA. To reduce risk of vascular mortality in suspected acute MI. To reduce combined risk of death and nonfatal MI after MI or unstable angina pectoris. To reduce combined risk of MI and sudden death in chronic stable angina. Revascularization procedures.

Adult:

Ischemic stroke and TIA: 50–325mg once daily. Suspected acute MI: 160–162.5mg once daily (start as soon as MI suspected) then for at least 30 days post-MI. Prevention of recurrent MI, unstable angina pectoris, chronic stable angina: 75–325mg once daily. Coronary artery bypass graft: 325mg once daily (start 6 hours after procedure) for 1yr. Percutaneous transluminal coronary angioplasty: 325mg 2hrs before surgery, then 160–325mg once daily. Carotid endarterectomy: 80mg once daily to 650mg twice daily (start before surgery).

Children:

Not recommended.

Contraindications:

NSAID allergy. Viral infection in children and teenagers. 3rd trimester pregnancy.

Warnings/Precautions:

History of asthma or peptic ulcer. Severe hepatic or renal dysfunction. Bleeding disorders. Diabetes. Gout. Pregnancy, nursing mothers: not recommended.

Interactions:

Potentiates anticoagulants, hypoglycemics, methotrexate, acetazolamide, valproic acid, highly protein-bound drugs. Urinary alkalinizers, antacids, corticosteroids may increase excretion. May antagonize ACE inhibitors, β-blockers, diuretics, uricosurics. Increased bleeding risk with NSAIDs or chronic, heavy alcohol use. NSAIDs increase risk of renal dysfunction.

Pharmacological Class:

Antiplatelet.

Adverse Reactions:

GI upset/bleed, prolonged bleeding time, anaphylaxis, salicylism.

Generic Availability:

81mg, 325mg (YES); 500mg (NO)

How Supplied:

Tabs 81mg—36, 120; 325mg—100, 250; 500mg—60, 150

Sign Up for Free e-newsletters